跳至主要内容
临床试验/IRCT20210411050925N1
IRCT20210411050925N1尚未招募3 期

Evaluation of the effect of melatonin in the treatment of patients with COVID19 compared ?with placebo.

Iran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 no limit(—)
性别
All

入选标准

  • Patients with positive RT-PCR for COVID19
  • Ability to sign consent and sufficient literacy
  • No history of melatonin use during the study
  • Admission in ICU
  • Age over 20 years

排除标准

  • Other systemic diseases (such as uncontrollable hypertension, uncontrolled diabetes, depression, elevated liver enzymes more than 3 times normal, cirrhosis, chronic kidney disease with GFR less than 30 cc / min)
  • Allergy to melatonin
  • Usage of anticoagulants such as warfarin or heparin with therapeutic doses
  • Under mechanical ventilation

研究者

相似试验

Evaluation of the effect of melatonin on COVID 19 | 临床试验